Clinical Trial Details


Research Study Summary

Changes in Biochemical Parameters After Viscosupplementaion of the Knee


This study is being done to evaluate how Euflexxa works to decrease knee pain in osteoarthritis, a condition characterized by a worn down knee. Euflexxa is a Viscosupplementation agent; these agents are currently being used and have been used for the past few years in orthopedic surgery. Euflexxa helps restore the ability of synovial fluid (fluid in the knee) to cushion, lubricate, and protect the knee; this should decrease the pain associated with early osteoarthritis and may prevent the need for more invasive interventions such as knee replacement.

Patient Inclusion Criteria:

  • Age 30 to 60
  • Has a BMI of less than 30
  • Has osteoarthritis K-L grade 1 or 2
  • Indicated for injections of Hyaluroinic acid supplementation

Patient Exclusion Criteria:

  • Patients who have Rheumatoid Arthritis
  • Having had previous knee surgery
  • Ligamentous damage
  • Previous steroid injections

To Learn more

CW ID: 181607
Date Last Changed: July 18, 2013

Clinical Trial Snapshot

Both Male and Female
30 to 60 Years
Overall Status
Facility Type


Sun Jin Kim, MD
The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore
Department of Obstetrics and Gynecology and Women's Health
111 East 210th Street
Bronx, NY 10467
Phone: (718) 920-2060

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.